A Survey on Data Reproducibility in Cancer Research Provides Insights into Our Limited Ability to Translate Findings from the Laboratory to the Clinic

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Mobley, Aaron ^a   Linder, Suzanne K ^a   Braeuer, Russell ^a   Ellis, Lee M ^a   Zwelling, Leonard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CENTER; CANCER RESEARCH; COMPUTER SYSTEM; DATA PROCESSING; HEALTH SURVEY; HUMAN; PEER REVIEW; PUBLICATION; PUBLISHING; REPRODUCIBILITY; TRANSLATIONAL RESEARCH;

DATA COLLECTION; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84877752060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063221     Document Type: Article

References (6)

1. Begley CG, Ellis LM, (2012) Drug development: Raise standards for preclinical cancer research. Nature 483: 531-533.
2. Prinz F, Schlange T, Asadullah K, (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10: 712.
3. Zimmer C, (2012) A Sharp Rise in Retractions Prompts Calls for Reform. The New York Times.
4. Fang FC, Steen RG, Casadevall A, (2012) Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci U S A 109: 17028-17033.
5. Neaves W, (2012) The roots of research misconduct. Nature 488: 121-122.
6. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, et al. (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490: 187-191.